Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis
Titel:
Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis
Auteur:
Amaral, T. Chatziioannou, E. Nuebling, A. Sinnberg, T. Niessner, H. Leiter, U. Dwarkasing, J. Arentsen, T. Groß, C. Eggermont, A. Flatz, L. Forchhammer, S.